EMMPRIN/CD147 expression is associated with disease-free survival of patients with colorectal cancer

[1]  Fei Wu,et al.  Overexpressions of RACK1 and CD147 Associated with Poor Prognosis in Stage T1 Pulmonary Adenocarcinoma , 2013, Annals of Surgical Oncology.

[2]  W. Weichert,et al.  High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer. , 2012, Human pathology.

[3]  Yu-qin Pan,et al.  CD147 silencing via RNA interference reduces tumor cell invasion, metastasis and increases chemosensitivity in pancreatic cancer cells. , 2012, Oncology reports.

[4]  A. Hongo,et al.  Role of emmprin in endometrial cancer , 2012, BMC Cancer.

[5]  W. Zhong,et al.  Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas , 2012, Clinical and Translational Oncology.

[6]  S. Piao,et al.  Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma , 2012, Journal of Cancer Research and Clinical Oncology.

[7]  A. Longatto-Filho,et al.  CD147 overexpression allows an accurate discrimination of bladder cancer patients' prognosis. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  Wei Zhang,et al.  Clinical Impact of HAb18G/CD147 Expression in Esophageal Squamous Cell Carcinoma , 2011, Digestive Diseases and Sciences.

[9]  R. Reis,et al.  Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer , 2011, BMC Cancer.

[10]  Yu-qi Fan,et al.  Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-κB signaling pathway. , 2011, International journal of molecular medicine.

[11]  C. Fan,et al.  Effects and relationship of ERK1 and ERK2 in interleukin-1β-induced alterations in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes. , 2011, International journal of molecular medicine.

[12]  Fangfang Liu,et al.  Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma , 2010, Breast Cancer Research and Treatment.

[13]  G. Gilliland,et al.  Structure of the EMMPRIN N‐terminal domain 1: Dimerization via β‐strand swapping , 2009, Proteins.

[14]  A. Jemal,et al.  Worldwide Variations in Colorectal Cancer , 2009, CA: a cancer journal for clinicians.

[15]  Che Zhang,et al.  Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas , 2009, European Journal of Pediatrics.

[16]  Ning Wen,et al.  Crystal Structure of HAb18G/CD147 , 2008, Journal of Biological Chemistry.

[17]  J. Meyerhardt,et al.  Adjuvant Treatment of Colorectal Cancer , 2007, CA: a cancer journal for clinicians.

[18]  汪建平.  结直肠癌筛查的现状和未来 , 2006 .

[19]  W. Jin,et al.  Extracellular Matrix Metalloproteinase Inducer (CD147) Confers Resistance of Breast Cancer Cells to Anoikis through Inhibition of Bim* , 2006, Journal of Biological Chemistry.

[20]  Jean Wu,et al.  Increased EMMPRIN (CD 147) expression during oral carcinogenesis. , 2006, Experimental and molecular pathology.

[21]  Yi Tang,et al.  Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. , 2005, Cancer research.

[22]  T. Hoang‐Xuan,et al.  EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. , 2005, Biochimie.

[23]  Rongsong Li,et al.  Emmprin Promotes Anchorage-Independent Growth in Human Mammary Carcinoma Cells by Stimulating Hyaluronan Production , 2004, Cancer Research.

[24]  Yi Tang,et al.  Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. , 2004, Molecular cancer research : MCR.

[25]  S. Curran,et al.  Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. , 2000, European journal of cancer.

[26]  理恵 西馬場.  CD147-targeting siRNA inhibits cell-matrix adhesion of human malignant melanoma cells by phosphorylating focal adhesion kinase , 2012 .

[27]  F. Calvo,et al.  Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction. , 2005, The American journal of pathology.